BioCryst Pharmaceuticals, Inc.: BioCryst Announces Preliminary Full Year 2024 ORLADEYO (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
ORLADEYO net revenue expected to be between $515-$535 million in 2025- -Total revenue (including RAPIVAB®) expected to be between $540-$560 million in 2025- -Company achieved operating profit in 2024 ...
WCBD Charleston on MSN54m
NC hospitals stock up, prepare for incoming winter weather
As people in the Triangle prepare for incoming weather, medical facilities like UNC Health hospitals do too. Dr. Abhi ...
Hosted on MSN18m
Top 110 GK Questions For Class 9, With Comprehensive Answers
Class nine students are on the brink of an educational breakthrough. While they have already amassed a lot of academic ...